Therapy to Elevate CD4 Counts in HIV-1 Disease

计划入组 4 人 · 首次发布于 2011 年 6 月 9 日

Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency

计划入组 50 人 · 首次发布于 2007 年 4 月 13 日

Neutrophil Elastase, Elastase Alpha-1 Proteinase, Periodontitis, Gingival Crevicular Fluid and Acute Coronary Syndrome

计划入组 43 人 · 首次发布于 2021 年 3 月 5 日

Alpha-1-proteinase inhibitor(Aralast, Glassia, Prolastin, Prolastin-C, Respreeza, Zemaira)

alpha-1 proteinase inhibitor (pulmonary disease)

DYRK-1 alpha protein kinase inhibitors (Carna)

ALPHA-1 FOUNDATION, INC.

United States

Protein Sciences Corporation

United States

NHI-1

United States

FDA Approves Larger Vial Sizes of Takeda's GLASSIA for Alpha-1 Antitrypsin Deficiency

Regeneron Partners with Tessera in $275M Gene Editing Deal for Alpha-1 Antitrypsin Deficiency Treatment

Sanofi's Experimental Alpha-1 Antitrypsin Therapy Outperforms Standard Care in Phase 3 Trial